PIK3CA and ovarian carcinoma: Study from 2021 showed that inhibition of p-FAK by the FAK inhibitor (BI853520) reduced the expression of proteins that are part of the PI3K/Akt/mTOR pathway and subsequently reduced the invasive potential of ovarian cancer cells (SKOV3 cells and OVCAR3 cells)47.